Jonathan Carapetis
#80,839
Most Influential Person Now
Australian paediatric physician
Jonathan Carapetis's AcademicInfluence.com Rankings
Jonathan Carapetisphilosophy Degrees
Philosophy
#6189
World Rank
#9186
Historical Rank
Logic
#3382
World Rank
#4531
Historical Rank
Download Badge
Philosophy
Why Is Jonathan Carapetis Influential?
(Suggest an Edit or Addition)According to Wikipedia, Jonathan Carapetis is an Australian paediatric physician with particular expertise in infectious disease and Indigenous child health. He is a Winthrop Professor at the University of Western Australia, an infectious diseases consultant at Princess Margaret Hospital for Children, and an Honorary Distinguished Research Fellow of the Walter and Eliza Hall Institute of Medical Research. Carapetis is the Director of the Telethon Kids Institute in Perth, Western Australia.
Jonathan Carapetis's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 (2012) (11746)
- A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 (2012) (9252)
- Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 (2012) (8152)
- Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 (2012) (7185)
- Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 (2015) (5270)
- Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015 (2016) (4293)
- Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013 (2015) (4152)
- The global burden of group A streptococcal diseases. (2005) (2574)
- Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019 (2020) (2362)
- Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019 (2020) (2362)
- Global, Regional, and National Burden of Cardiovascular Diseases for 10 Causes, 1990 to 2015 (2017) (2357)
- Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying the epidemiological transition (2015) (1618)
- Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 (2016) (1580)
- Global, regional, and national levels of neonatal, infant, and under-5 mortality during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 (2014) (673)
- World Heart Federation criteria for echocardiographic diagnosis of rheumatic heart disease—an evidence-based guideline (2012) (635)
- Global, Regional, and National Burden of Rheumatic Heart Disease, 1990–2015 (2017) (629)
- Global emm type distribution of group A streptococci: systematic review and implications for vaccine development. (2009) (487)
- Revision of the Jones Criteria for the Diagnosis of Acute Rheumatic Fever in the Era of Doppler Echocardiography: A Scientific Statement From the American Heart Association (2015) (445)
- Acute rheumatic fever and rheumatic heart disease (2016) (403)
- Antibiotic prophylaxis and recurrent urinary tract infection in children. (2009) (400)
- Group a streptococcal diseases and their global burden. (2013) (280)
- Acute rheumatic fever: a chink in the chain that links the heart to the throat? (2004) (269)
- A systematic and functional classification of Streptococcus pyogenes that serves as a new tool for molecular typing and vaccine development. (2014) (239)
- Rheumatic heart disease in developing countries. (2007) (237)
- Skin infections and infestations in Aboriginal communities in northern Australia (2000) (236)
- Position statement of the World Heart Federation on the prevention and control of rheumatic heart disease (2013) (226)
- Acute rheumatic fever and rheumatic heart disease in the Top End of Australia's Northern Territory (1996) (221)
- The Global Epidemiology of Impetigo: A Systematic Review of the Population Prevalence of Impetigo and Pyoderma (2015) (189)
- Evaluation of a screening protocol using auscultation and portable echocardiography to detect asymptomatic rheumatic heart disease in Tongan schoolchildren (2008) (189)
- Acute rheumatic fever – Authors' reply (2005) (188)
- Success of a scabies control program in an Australian aboriginal community. (1997) (184)
- Effectiveness of clindamycin and intravenous immunoglobulin, and risk of disease in contacts, in invasive group a streptococcal infections. (2014) (184)
- Low rates of streptococcal pharyngitis and high rates of pyoderma in Australian aboriginal communities where acute rheumatic fever is hyperendemic. (2006) (184)
- Acute Rheumatic Fever and Rheumatic Heart Disease: Incidence and Progression in the Northern Territory of Australia, 1997 to 2010 (2013) (175)
- Cumulative incidence of rheumatic fever in an endemic region: a guide to the susceptibility of the population? (2000) (168)
- Contrasting molecular epidemiology of group A streptococci causing tropical and nontropical infections of the skin and throat. (2000) (164)
- Epidemiology of nasopharyngeal carriage of respiratory bacterial pathogens in children and adults: cross-sectional surveys in a population with high rates of pneumococcal disease (2010) (156)
- Invasive Group A Streptococcal Disease (2012) (152)
- Disease burden and health-care clinic attendances for young children in remote aboriginal communities of northern Australia. (2008) (150)
- Rheumatic fever in Indigenous Australian children (2010) (148)
- Some of the people, some of the time: susceptibility to acute rheumatic fever. (2009) (146)
- Community Epidemiology of Human Metapneumovirus, Human Coronavirus NL63, and Other Respiratory Viruses in Healthy Preschool-Aged Children Using Parent-Collected Specimens (2007) (143)
- High Burden of Impetigo and Scabies in a Tropical Country (2009) (137)
- Updated model of group A Streptococcus M proteins based on a comprehensive worldwide study. (2013) (128)
- Rheumatic fever in a high incidence population: the importance of monoarthritis and low grade fever (2001) (126)
- Status of research and development of vaccines for Streptococcus pyogenes. (2016) (122)
- Burden of Acute Sore Throat and Group A Streptococcal Pharyngitis in School-aged Children and Their Families in Australia (2007) (120)
- Group A streptococcal infections in children (2007) (120)
- Group A streptococcal vaccines: facts versus fantasy (2009) (119)
- Screening for rheumatic heart disease: current approaches and controversies (2013) (117)
- The Drakensberg declaration on the control of rheumatic fever and rheumatic heart disease in Africa. (2006) (115)
- Rheumatic Heart Disease in Asia (2008) (113)
- Clinical and epidemiological features of group A streptococcal bacteraemia in a region with hyperendemic superficial streptococcal infection (1999) (112)
- Echocardiographic Screening for Rheumatic Heart Disease in High and Low Risk Australian Children (2014) (112)
- A Regional Initiative to Reduce Skin Infections amongst Aboriginal Children Living in Remote Communities of the Northern Territory, Australia (2009) (109)
- Global Disease Burden of Group A Streptococcus (2016) (105)
- Rheumatic Heart Disease Worldwide: JACC Scientific Expert Panel. (2018) (104)
- Use of a Single-Nucleotide Polymorphism Genotyping System To Demonstrate the Unique Epidemiology of Methicillin-Resistant Staphylococcus aureus in Remote Aboriginal Communities (2006) (104)
- Seven key actions to eradicate rheumatic heart disease in Africa: the Addis Ababa communiqué (2016) (103)
- Group A Streptococcus, Acute Rheumatic Fever and Rheumatic Heart Disease: Epidemiology and Clinical Considerations (2017) (103)
- Increasing severity of invasive group A streptococcal disease in Australia: clinical and molecular epidemiological features and identification of a new virulent M-nontypeable clone. (1995) (101)
- Group A streptococcal vaccines: paving a path for accelerated development. (2013) (99)
- High prevalence of asymptomatic vitamin D and iron deficiency in East African immigrant children and adolescents living in a temperate climate (2007) (99)
- Global epidemiology of valvular heart disease (2021) (99)
- Case-control evaluation of the effectiveness of the G1P[8] human rotavirus vaccine during an outbreak of rotavirus G2P[4] infection in central Australia. (2011) (99)
- Atlas of group A streptococcal vaccine candidates compiled using large-scale comparative genomics (2019) (99)
- Rheumatic chorea in northern Australia: a clinical and epidemiological study (1999) (95)
- Global research priorities in rheumatic fever and rheumatic heart disease (2011) (95)
- The epidemiology of invasive group A streptococcal disease in Victoria, Australia (2007) (94)
- The Path to Group A Streptococcus Vaccines: World Health Organization Research and Development Technology Roadmap and Preferred Product Characteristics (2019) (94)
- Skin disorders, including pyoderma, scabies, and tinea infections. (2009) (94)
- Opsonic human antibodies from an endemic population specific for a conserved epitope on the M protein of group A streptococci (1996) (91)
- An Australian guideline for rheumatic fever and rheumatic heart disease: an abridged outline (2007) (91)
- Community Management of Endemic Scabies in Remote Aboriginal Communities of Northern Australia: Low Treatment Uptake and High Ongoing Acquisition (2009) (91)
- Post-infectious group A streptococcal autoimmune syndromes and the heart. (2015) (90)
- Infectious diseases of the fetus and newborn infant (5th edn) (2002) (90)
- Impact of an Ivermectin Mass Drug Administration on Scabies Prevalence in a Remote Australian Aboriginal Community (2015) (89)
- Streptococcus pyogenes recruits collagen via surface‐bound fibronectin: a novel colonization and immune evasion mechanism (2003) (87)
- Short-course oral co-trimoxazole versus intramuscular benzathine benzylpenicillin for impetigo in a highly endemic region: an open-label, randomised, controlled, non-inferiority trial (2014) (86)
- Epidemiology and prevention of group A streptococcal infections: acute respiratory tract infections, skin infections, and their sequelae at the close of the twentieth century. (1999) (86)
- As a Bacterial Culture Medium, Citrated Sheep Blood Agar Is a Practical Alternative to Citrated Human Blood Agar in Laboratories of Developing Countries (2006) (81)
- Strain prevalence, rather than innate virulence potential, is the major factor responsible for an increase in serious group A streptococcus infections. (2007) (81)
- Prospective Study of a Real-Time PCR That Is Highly Sensitive, Specific, and Clinically Useful for Diagnosis of Meningococcal Disease in Children (2004) (81)
- Subclinical carditis in rheumatic fever: a systematic review. (2007) (78)
- Burden of cardiovascular diseases in the Eastern Mediterranean Region, 1990–2015: findings from the Global Burden of Disease 2015 study (2017) (78)
- Hyporesponsiveness to re-challenge dose following pneumococcal polysaccharide vaccine at 12 months of age, a randomized controlled trial. (2010) (76)
- Preventing recurrent rheumatic fever: the role of register based programmes (2005) (76)
- High prevalence of rheumatic heart disease by clinical and echocardiographic screening among children in Fiji. (2009) (75)
- Rotavirus and the indigenous children of the Australian outback: monovalent vaccine effective in a high-burden setting. (2009) (75)
- Acute rheumatic fever (2005) (73)
- Prevention and treatment of rheumatic heart disease in the developing world (2009) (71)
- Clinic Attendances during the First 12 Months of Life for Aboriginal Children in Five Remote Communities of Northern Australia (2013) (71)
- The microbiology of impetigo in Indigenous children: associations between Streptococcus pyogenes, Staphylococcus aureus,scabies, and nasal carriage (2014) (70)
- Superantigen genes in group A streptococcal isolates and their relationship with emm types. (2008) (70)
- Pneumococcal vaccination and otitis media in Australian Aboriginal infants: comparison of two birth cohorts before and after introduction of vaccination (2009) (70)
- Immunogenicity following one, two, or three doses of the 7-valent pneumococcal conjugate vaccine. (2009) (68)
- Prospective Surveillance of Streptococcal Sore Throat in a Tropical Country (2009) (67)
- Pneumococcal Nasopharyngeal Carriage following Reduced Doses of a 7-Valent Pneumococcal Conjugate Vaccine and a 23-Valent Pneumococcal Polysaccharide Vaccine Booster (2010) (65)
- Group A streptococcus, pyoderma, and rheumatic fever (1996) (64)
- Pilot study of nurse-led rheumatic heart disease echocardiography screening in Fiji – a novel approach in a resource-poor setting (2012) (62)
- Acute rheumatic fever and rheumatic heart disease in Fiji: prospective surveillance, 2005–2007 (2009) (62)
- emm and C-Repeat Region Molecular Typing of Beta-Hemolytic Streptococci in a Tropical Country: Implications for Vaccine Development (2009) (59)
- Chest X-ray-confirmed pneumonia in children in Fiji. (2005) (58)
- Mortality due to acute rheumatic fever and rheumatic heart disease in the Northern Territory: a preventable cause of death in Aboriginal people (1999) (57)
- Validation of an Integrated Management of Childhood Illness algorithm for managing common skin conditions in Fiji. (2009) (56)
- Focused cardiac ultrasound screening for rheumatic heart disease by briefly trained health workers: a study of diagnostic accuracy. (2016) (55)
- Multiple strains of Streptococcus pyogenes in skin sores of aboriginal Australians (1995) (54)
- Epidemiology of Streptococcus dysgalactiae subsp. equisimilis in Tropical Communities, Northern Australia (2007) (54)
- Normal Ranges of Streptococcal Antibody Titers Are Similar Whether Streptococci Are Endemic to the Setting or Not (2008) (54)
- The fall and rise of Group A Streptococcus diseases (2018) (54)
- Acute rheumatic fever and rheumatic heart disease in indigenous populations. (2009) (53)
- Are minor echocardiographic changes associated with an increased risk of acute rheumatic fever or progression to rheumatic heart disease? (2015) (53)
- The prevention, diagnosis and management of central venous line infections in children. (2015) (53)
- Skin disease in the first two years of life in Aboriginal children in East Arnhem Land (2011) (52)
- Evaluating the use of penicillin to control outbreaks of acute poststreptococcal glomerulonephritis. (1999) (52)
- The burden and cost of hospitalised varicella and zoster in Australian children. (2004) (51)
- Rheumatic Heart Disease Severity, Progression and Outcomes: A Multi‐State Model (2017) (51)
- Genome-wide analysis of genetic risk factors for rheumatic heart disease in Aboriginal Australians provides support for pathogenic molecular mimicry (2017) (51)
- Preventing rheumatic heart disease in Australia (1998) (51)
- Progress Toward a Global Group A Streptococcal Vaccine (2013) (51)
- Improvement in rheumatic fever and rheumatic heart disease management and prevention using a health centre-based continuous quality improvement approach (2013) (50)
- Is Streptococcus pyogenes Resistant or Susceptible to Trimethoprim-Sulfamethoxazole? (2012) (49)
- Working towards a group A streptococcal vaccine: report of a collaborative Trans-Tasman workshop. (2014) (49)
- Parasitic diseases of remote Indigenous communities in Australia. (2010) (49)
- Prospective Surveillance of Invasive Group A Streptococcal Disease, Fiji, 2005–2007 (2009) (49)
- Group A streptococci from a remote community have novel multilocus genotypes but share emm types and housekeeping alleles with isolates from worldwide sources. (2004) (48)
- Randomized, controlled trial comparing once daily and three times daily gentamicin in children with urinary tract infections (2001) (47)
- Molecular typing of Streptococcus pyogenes from remote Aboriginal communities where rheumatic fever is common and pyoderma is the predominant streptococcal infection (2007) (46)
- Protocol for the systematic review of the prevention, treatment and public health management of impetigo, scabies and fungal skin infections in resource-limited settings (2016) (46)
- Contemporary Incidence and Prevalence of Rheumatic Fever and Rheumatic Heart Disease in Australia Using Linked Data: The Case for Policy Change (2020) (46)
- Strongyloides seroprevalence before and after an ivermectin mass drug administration in a remote Australian Aboriginal community (2017) (45)
- Evaluation of safety and immunogenicity of a group A streptococcus vaccine candidate (MJ8VAX) in a randomized clinical trial (2018) (45)
- Utility of auscultatory screening for detecting rheumatic heart disease in high‐risk children in Australia's Northern Territory (2013) (45)
- Trough Concentrations of Vancomycin: Adult Therapeutic Targets Are Not Appropriate for Children (2012) (45)
- The clinical and molecular epidemiology of Staphylococcus aureus infections in Fiji (2014) (44)
- The School readiness of Australian Indigenous children : a review of the literature (2008) (43)
- The dynamic nature of group A streptococcal epidemiology in tropical communities with high rates of rheumatic heart disease (2007) (43)
- Controlling acute rheumatic fever and rheumatic heart disease in developing countries: are we getting closer? (2015) (42)
- Pediatric sepsis in the developing world. (2015) (42)
- Rheumatic heart disease in Indigenous children in northern Australia: differences in prevalence and the challenges of screening (2015) (41)
- East African immigrant children in Australia have poor immunisation coverage (2011) (40)
- Management of invasive group A streptococcal infections. (2014) (40)
- Ten-year follow up of a cohort with rheumatic heart disease (RHD). (1997) (39)
- Trial of a developmental screening tool in remote Australian Aboriginal communities: A cautionary tale (2011) (39)
- Acute Hematogenous Osteomyelitis in Children (2004) (38)
- The clinical course of acute otitis media in high-risk Australian Aboriginal children: a longitudinal study (2005) (38)
- High burden of invasive β-haemolytic streptococcal infections in Fiji (2007) (37)
- Impact of heart disease on maternal, fetal and neonatal outcomes in a low-resource setting (2018) (37)
- The inequitable burden of group A streptococcal diseases in Indigenous Australians (2016) (37)
- How Many Doses Make a Difference? An Analysis of Secondary Prevention of Rheumatic Fever and Rheumatic Heart Disease (2018) (36)
- The need for a global perspective on heart valve disease epidemiology. The SHVD working group on epidemiology of heart valve disease founding statement. (2008) (36)
- A National Prospective Surveillance Study of Acute Rheumatic Fever in Australian Children (2013) (36)
- Sulfamethoxazole-Trimethoprim (Cotrimoxazole) for Skin and Soft Tissue Infections Including Impetigo, Cellulitis, and Abscess (2017) (35)
- The "surreptitious Staphylococcus": Staphylococcus lugdunensis endocarditis in a child. (2002) (35)
- ABRACADABRA aids Indigenous and non-Indigenous early literacy in Australia: Evidence from a multisite randomized controlled trial (2013) (35)
- The 2015 revision of the Jones criteria for the diagnosis of acute rheumatic fever: implications for practice in low-income and middle-income countries (2015) (35)
- Apparent contrasting rates of pharyngitis and pyoderma in regions where rheumatic heart disease is highly prevalent. (2007) (34)
- Secondary Antibiotic Prophylaxis for Latent Rheumatic Heart Disease. (2021) (34)
- Underdiagnosis of acute rheumatic fever in primary care settings in a developing country (2009) (34)
- The burden of group A streptococcal pharyngitis in Melbourne families. (2004) (34)
- Recovering Streptococci from the Throat, a Practical Alternative to Direct Plating in Remote Tropical Communities (2006) (34)
- Echocardiographic Screening for Rheumatic Heart Disease in Indigenous Australian Children: A Cost–Utility Analysis (2017) (33)
- Rheumatic heart disease and its control in the Pacific (2009) (33)
- Rheumatic heart disease: infectious disease origin, chronic care approach (2017) (32)
- Safety and immunogenicity of the 23-valent pneumococcal polysaccharide vaccine at 12 months of age, following one, two, or three doses of the 7-valent pneumococcal conjugate vaccine in infancy. (2010) (32)
- Towards Improving Point-of-Care Diagnosis of Non-malaria Febrile Illness: A Metabolomics Approach (2016) (32)
- Functional analysis of IgA antibodies specific for a conserved epitope within the M protein of group A streptococci from Australian Aboriginal endemic communities. (1999) (31)
- Long-Term Outcomes From Acute Rheumatic Fever and Rheumatic Heart Disease (2016) (31)
- Primary prevention of rheumatic fever in the 21st century: evaluation of a national programme. (2018) (31)
- Pneumococcal nasopharyngeal carriage and patterns of penicillin resistance in young children in Fiji (2006) (30)
- Impetigo and scabies - Disease burden and modern treatment strategies. (2016) (30)
- The stark reality of rheumatic heart disease. (2015) (30)
- Improving Delivery of Secondary Prophylaxis for Rheumatic Heart Disease in a High‐Burden Setting: Outcome of a Stepped‐Wedge, Community, Randomized Trial (2018) (29)
- Opsonophagocytic activity following a reduced dose 7-valent pneumococcal conjugate vaccine infant primary series and 23-valent pneumococcal polysaccharide vaccine at 12 months of age. (2011) (29)
- Screening for rheumatic heart disease: quality and agreement of focused cardiac ultrasound by briefly trained health workers (2016) (28)
- Community-associated methicillin-resistant Staphylococcus aureus skin infections in the tropics. (2011) (28)
- Use of health services by remote dwelling Aboriginal infants in tropical northern Australia: a retrospective cohort study (2012) (28)
- Leuconostoc sepsis in association with continuous enteral feeding: two case reports and a review. (1994) (28)
- The case for global investment in rheumatic heart-disease control (2014) (28)
- High burden of invasive beta-haemolytic streptococcal infections in Fiji. (2008) (28)
- Development of Group A streptococcal vaccines: an unmet global health need (2016) (28)
- Clinical epidemiology of rheumatic fever and rheumatic heart disease in tropical Australia. (1997) (28)
- Outcomes of cardiac valve replacement for rheumatic heart disease in aboriginal Australians (1999) (27)
- Fetal Alcohol Spectrum Disorder (FASD): Knowledge, attitudes, experiences and practices of the Western Australian youth custodial workforce. (2018) (27)
- Improving delivery of secondary prophylaxis for rheumatic heart disease in remote Indigenous communities: study protocol for a stepped-wedge randomised trial (2016) (27)
- Initiating an undiagnosed diseases program in the Western Australian public health system (2017) (27)
- Towards understanding the pathogenesis of rheumatic fever. (1996) (27)
- Ending rheumatic heart disease in Australia: the evidence for a new approach (2020) (26)
- Pediatric rheumatic heart disease in the developing world: echocardiographic versus clinical screening (2008) (26)
- An economic case for a vaccine to prevent group A streptococcus skin infections. (2018) (26)
- A pilot study of the quality of informed consent materials for Aboriginal participants in clinical trials (2005) (25)
- Persistence of acute rheumatic fever in a tertiary children's hospital (2011) (25)
- Qualitative Evaluation of a Complex Intervention to Improve Rheumatic Heart Disease Secondary Prophylaxis (2018) (24)
- Rheumatic heart disease in Timor‐Leste school students: an echocardiography‐based prevalence study (2018) (24)
- Defining and Assessing the School Readiness of Indigenous Australian Children (2011) (24)
- Impact of single dose azithromycin on group A streptococci in the upper respiratory tract and skin of Aboriginal children (2002) (24)
- Preventing heart failure: a position paper of the Heart Failure Association in collaboration with the European Association of Preventive Cardiology (2022) (24)
- PneuMum: Impact from a randomised controlled trial of maternal 23-valent pneumococcal polysaccharide vaccination on middle ear disease amongst Indigenous infants, Northern Territory, Australia. (2015) (24)
- Dysregulated IL-1&bgr;-GM-CSF Axis in Acute Rheumatic Fever That Is Limited by Hydroxychloroquine (2018) (23)
- Severe lower limb cellulitis: defining the epidemiology and risk factors for primary episodes in a population-based case-control study. (2018) (23)
- Treatment, prevention and public health management of impetigo, scabies, crusted scabies and fungal skin infections in endemic populations: a systematic review (2019) (23)
- Scabies and risk of skin sores in remote Australian Aboriginal communities: A self-controlled case series study (2018) (23)
- PM214 Trends in the Global Burden of Rheumatic Heart Disease During 1990-2013: Findings From the Global Burden Of Disease 2013 Study (2016) (23)
- The future of acute rheumatic fever and rheumatic heart disease in Australia (2012) (23)
- Controlled human infection for vaccination against Streptococcus pyogenes (CHIVAS): Establishing a group A Streptococcus pharyngitis human infection study. (2019) (23)
- Successful treatment of foscarnet-resistant herpes simplex stomatitis with intravenous cidofovir in a child. (2001) (22)
- Preliminary validation of a novel high-resolution melt-based typing method based on the multilocus sequence typing scheme of Streptococcus pyogenes. (2011) (22)
- Trimethoprim‐sulfamethoxazole compared with benzathine penicillin for treatment of impetigo in Aboriginal children: A pilot randomised controlled trial (2010) (22)
- Development of an opsonophagocytic killing assay for group a streptococcus. (2018) (22)
- Treatment of sore throat in light of the Cochrane verdict: is the jury still out? (2002) (22)
- Standardising and Assessing Digital Images for Use in Clinical Trials: A Practical, Reproducible Method That Blinds the Assessor to Treatment Allocation (2014) (21)
- Ivermectin worthy of further investigation. (2009) (21)
- Invasive Staphylococcus aureus Infections in Children in Tropical Northern Australia. (2014) (21)
- The high burden of rheumatic heart disease found on autopsy in Fiji (2008) (21)
- The Importance of Scabies Coinfection in the Treatment Considerations for Impetigo (2016) (21)
- Pneumococcal conjugate vaccines PREVenar13 and SynflorIX in sequence or alone in high-risk Indigenous infants (PREV-IX_COMBO): protocol of a randomised controlled trial (2015) (20)
- Adherence to secondary prophylaxis for rheumatic heart disease is underestimated by register data (2017) (20)
- Diversity of emm sequence types in group A beta-haemolytic streptococci in two remote Northern Territory Indigenous communities: implications for vaccine development. (2010) (20)
- Disparity in Mortality From Rheumatic Heart Disease in Indigenous Australians (2015) (20)
- Extensive Diversity of Streptococcus pyogenes in a Remote Human Population Reflects Global-Scale Transmission Rather than Localised Diversification (2013) (19)
- Whole genome sequencing reveals extensive community-level transmission of group A Streptococcus in remote communities (2016) (19)
- B‐cell antigen D8/17 is a marker of rheumatic fever susceptibility in Aboriginal Australians and can be tested in remote settings (2006) (19)
- Ability of clinical isolates of group A streptococci to adhere to and invade HEp-2 epithelial cells. (1998) (19)
- Joining the dots: The links between education and health and implications for Indigenous children (2009) (18)
- A systematic review of the evidence that swimming pools improve health and wellbeing in remote Aboriginal communities in Australia (2016) (18)
- Clinical development strategy for a candidate group A streptococcal vaccine. (2017) (18)
- Rheumatic heart disease in pregnancy: How can health services adapt to the needs of Indigenous women? A qualitative study (2018) (18)
- Clinical outcomes for young people with screening-detected and clinically-diagnosed rheumatic heart disease in Fiji. (2017) (18)
- Susceptibility to Acute Rheumatic Fever Based on Differential Expression of Genes Involved in Cytotoxicity, Chemotaxis, and Apoptosis (2013) (18)
- Preliminary consultation on preferred product characteristics of benzathine penicillin G for secondary prophylaxis of rheumatic fever (2016) (18)
- Understanding group A streptococcal pharyngitis and skin infections as causes of rheumatic fever: protocol for a prospective disease incidence study (2019) (17)
- Preventing urinary tract infections in early childhood. (2013) (17)
- The American Heart Association's Call to Action for Reducing the Global Burden of Rheumatic Heart Disease: A Policy Statement From the American Heart Association. (2020) (17)
- Acute rheumatic fever: an important differential diagnosis of septic arthritis. (2007) (17)
- Failure to vaccinate or failure of vaccine? Effectiveness of the 23-valent pneumococcal polysaccharide vaccine program in Indigenous adults in the Northern Territory of Australia. (2010) (16)
- Ascertaining infectious disease burden through primary care clinic attendance among young Aboriginal children living in four remote communities in Western Australia (2018) (16)
- Low positive predictive value of International Classification of Diseases, 10th Revision codes in relation to rheumatic heart disease: a challenge for global surveillance (2019) (16)
- Prevalence of Group A β-hemolytic Streptococcal Throat Carriage and Prospective Pilot Surveillance of Streptococcal Sore Throat in Ugandan School Children. (2020) (16)
- School-based intervention to address self-regulation and executive functioning in children attending primary schools in remote Australian Aboriginal communities (2020) (16)
- Demographics and utilisation of health services by paediatric refugees from East Africa: implications for service planning and provision. (2004) (16)
- Clinical implications of inducible beta-lactamase activity in Gram-negative bacteremia in children (2002) (16)
- A controlled human infection model of Streptococcus pyogenes pharyngitis (CHIVAS-M75): an observational, dose-finding study. (2021) (15)
- Control of rheumatic heart disease in the Pacific region. (2006) (15)
- Repeat pneumococcal polysaccharide vaccine in Indigenous Australian adults is associated with decreased immune responsiveness. (2017) (15)
- Advances in the diagnosis and management of central venous access device infections in children. (2011) (15)
- Investigation of trimethoprim/sulfamethoxazole resistance in an emerging sequence type 5 methicillin-resistant Staphylococcus aureus clone reveals discrepant resistance reporting. (2018) (15)
- Letter by Carapetis regarding article, "Is primary prevention of rheumatic fever the missing link in the control of rheumatic heart disease in Africa?". (2010) (14)
- Hospital admissions for skin infections among Western Australian children and adolescents from 1996 to 2012 (2017) (14)
- Single Parasternal-Long-Axis-View-Sweep Screening Echocardiographic Protocol to Detect Rheumatic Heart Disease: A Prospective Study of Diagnostic Accuracy. (2020) (14)
- Immunogenicity for 16 serotypes of a unique schedule of pneumococcal vaccines in a high-risk population. (2008) (14)
- Inter-rater and intra-rater reliability and agreement of echocardiographic diagnosis of rheumatic heart disease using the World Heart Federation evidence-based criteria (2019) (14)
- The second rheumatic heart disease forum report. (2013) (14)
- Rheumatic fever - identification, management and secondary prevention. (2012) (14)
- Continued challenge of rheumatic heart disease: the gap of understanding or the gap of implementation? (2013) (14)
- Epidemiology and risk factors for recurrent severe lower limb cellulitis: a longitudinal cohort study. (2018) (14)
- Serotype-specific avidity is achieved following a single dose of the 7-valent pneumococcal conjugate vaccine, and is enhanced by 23-valent pneumococcal polysaccharide booster at 12 months. (2011) (14)
- Indirect effects of childhood pneumococcal vaccination on pneumococcal carriage among adults and older children in Australian Aboriginal communities. (2007) (14)
- Rheumatic heart disease in Indigenous young peoples. (2021) (13)
- Current issues regarding the use of pneumococcal conjugate and polysaccharide vaccines in Australian children (2005) (13)
- A population pharmacokinetic study of benzathine benzylpenicillin G administration in children and adolescents with rheumatic heart disease: new insights for improved secondary prophylaxis strategies (2019) (13)
- The ORVAC trial protocol: a phase IV, double-blind, randomised, placebo-controlled clinical trial of a third scheduled dose of Rotarix rotavirus vaccine in Australian Indigenous infants to improve protection against gastroenteritis (2019) (12)
- Calculation of the age of the first infection for skin sores and scabies in five remote communities in northern Australia (2018) (12)
- Severe adverse events following benzathine penicillin G injection for rheumatic heart disease prophylaxis: cardiac compromise more likely than anaphylaxis (2019) (12)
- The economic and health burden of disease caused by Group A Streptococcus in New Zealand. (2020) (12)
- Healthy Skin Program: Guidelines for Community Control of Scabies, Skin Sores and Crusted Scabies in the Northern Territory (2003) (12)
- The diagnosis and management of chronic rheumatic heart disease--an Australian guideline. (2008) (12)
- Invasive Pneumococcal Disease in Fiji: Clinical Syndromes, Epidemiology, and the Potential Impact of Pneumococcal Conjugate Vaccine (2010) (12)
- The RHD Endgame Strategy; the blueprint to eliminate rheumatic heart disease in Australia by 2031 (2020) (11)
- High incidence of Haemophilus influenzae type b infection in children in Pacific island countries. (2003) (11)
- Transiently increased IgE responses in infants and pre-schoolers receiving only acellular Diphtheria-Pertussis-Tetanus (DTaP) vaccines compared to those initially receiving at least one dose of cellular vaccine (DTwP) - Immunological curiosity or canary in the mine? (2016) (10)
- High burden of infectious disease and antibiotic use in early life in Australian Aboriginal communities (2019) (10)
- SToP (See, Treat, Prevent) skin sores and scabies trial: study protocol for a cluster randomised, stepped-wedge trial for skin disease control in remote Western Australia (2019) (10)
- MMR immunisation. True anaphylaxis to MMR vaccine is extremely rare. (2001) (10)
- Comparison of Citrated Human Blood, Citrated Sheep Blood, and Defibrinated Sheep Blood Mueller-Hinton Agar Preparations for Antimicrobial Susceptibility Testing of Streptococcus pneumoniae Isolates (2010) (10)
- Prevalence of rheumatic heart disease in young adults from New Caledonia. (2015) (10)
- Practical challenges of conducting research into rheumatic fever in remote Aboriginal communities (2006) (9)
- Seasonal and regional patterns of lower leg cellulitis in Western Australia (2019) (9)
- Invasive group A streptococcal infection in the Northern Territory, Australia: Case report and review of the literature (2014) (9)
- The global burden of sore throat and group A Streptococcus pharyngitis: A systematic review and meta-analysis (2022) (9)
- Cross-sectional study of population-specific streptococcal antibody titres in Uganda (2020) (9)
- Lessons learned in the development of sustained release penicillin drug delivery systems for the prophylactic treatment of rheumatic heart disease (RHD) (2018) (9)
- Pediatric Staphylococcus aureus bacteremia: clinical spectrum and predictors of poor outcome. (2021) (9)
- Current issues in managing group A streptococcal infections. (2004) (9)
- Time to tackle rheumatic heart disease: Data needed to drive global policy dialogues (2018) (9)
- The NICE-GUT trial protocol: a randomised, placebo controlled trial of oral nitazoxanide for the empiric treatment of acute gastroenteritis among Australian Aboriginal children (2018) (8)
- Talking skin: attitudes and practices around skin infections, treatment options, and their clinical management in a remote region in Western Australia. (2019) (8)
- Rheumatic heart disease across the Western Pacific: not just a Pacific Island problem (2017) (8)
- Comparison of approaches to rheumatic fever surveillance across Organisation for Economic Co‐operation and Development countries (2015) (8)
- A subtle presentation of acute rheumatic fever in remote northern Australia. (1996) (8)
- Comparison of three methods for the recovery of skin pathogens from impetigo swabs collected in a remote community of Northern Territory, Australia. (2013) (8)
- Rheumatic Fever Follow-Up Study (RhFFUS) protocol: a cohort study investigating the significance of minor echocardiographic abnormalities in Aboriginal Australian and Torres Strait Islander children (2012) (8)
- Evolution, evidence and effect of secondary prophylaxis against rheumatic fever (2015) (8)
- Subcutaneous administration of benzathine benzylpenicillin G has favourable pharmacokinetic characteristics for the prevention of rheumatic heart disease compared with intramuscular injection: a randomized, crossover, population pharmacokinetic study in healthy adult volunteers. (2020) (8)
- Active Case Finding for Rheumatic Fever in an Endemic Country (2020) (8)
- Recurrent crepitant cellulitis caused by Clostridium perfringens. (2002) (8)
- Reframe the Behaviour: Evaluation of a training intervention to increase capacity in managing detained youth with fetal alcohol spectrum disorder and neurodevelopmental impairments (2020) (8)
- Formal Infectious Diseases Consultations at a Tertiary Pediatric Hospital: A 14-Year Review (2014) (8)
- Incidence of acute rheumatic fever in northern and western Uganda: a prospective, population-based study. (2021) (8)
- Author Correction: Atlas of group A streptococcal vaccine candidates compiled using large-scale comparative genomics (2019) (8)
- Interchangeability, immunogenicity and safety of a combined 10-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (Synflorix) and 13-valent-PCV (Prevenar13) schedule at 1-2-4-6 months: PREVIX_COMBO, a 3-arm randomised controlled trial (2021) (7)
- Sore throat: Is it such a big deal anymore? (2015) (7)
- Rotavirus in the Northern Territory before and after vaccination (2012) (7)
- Privacy legislation and research (2002) (7)
- Diagnosis and treatment of invasive group A streptococcal infections. (2008) (6)
- Long-term outcomes following rheumatic heart disease diagnosis in Australia (2021) (6)
- Barriers and Enablers of Health Service Utilisation for Childhood Skin Infections in Remote Aboriginal Communities of Western Australia (2020) (6)
- Secondary Prophylaxis is Important for the Prevention of Recurrent Rheumatic Fever in the Pacific (2011) (6)
- Impact of the 23-valent pneumococcal polysaccharide vaccination in pregnancy against infant acute lower respiratory infections in the Northern Territory of Australia (2018) (6)
- Efficacy of a trivalent influenza vaccine against seasonal strains and against 2009 pandemic H1N1: A randomized, placebo-controlled trial. (2016) (6)
- Searching for a technology-driven acute rheumatic fever test: the START study protocol (2021) (6)
- Serotypes of respiratory tract isolates of Streptococcus pneumoniae from Jamaican children. (2003) (6)
- Lessons learned in genetic research with Indigenous Australian participants (2020) (6)
- Nitazoxanide for the treatment of infectious diarrhoea in the Northern Territory, Australia 2007-2012. (2014) (5)
- Missing Piece Study protocol: prospective surveillance to determine the epidemiology of group A streptococcal pharyngitis and impetigo in remote Western Australia (2022) (5)
- Environmental and social determinants of acute rheumatic fever: a longitudinal cohort study (2019) (5)
- Increasing incidence of invasive group A streptococcal disease in Western Australia, particularly among Indigenous people (2021) (5)
- RE-AIM evaluation of a teacher-delivered programme to improve the self-regulation of children attending Australian Aboriginal community primary schools (2020) (5)
- Risk factors for group A streptococcal pharyngitis and skin infections: A case control study (2022) (5)
- Estimation of the force of infection and infectious period of skin sores in remote Australian communities using interval-censored data (2019) (5)
- Acute Rheumatic Fever and Chronic Rheumatic Disease (2014) (4)
- Rheumatic heart disease in The Gambia: clinical and valvular aspects at presentation and evolution under penicillin prophylaxis (2021) (4)
- Australian researchers oppose funding from the Foundation for a Smoke‐Free World (2018) (4)
- Rheumatic Heart Disease Worldwide JACC Scienti fi c Expert Panel (2018) (4)
- Controlling rheumatic heart disease in developing countries. (2006) (4)
- Treatment of Group A streptococcal infections (2010) (4)
- Myositis complicating benzathine penicillin-G injection in a case of rheumatic heart disease (2016) (4)
- Quality of benzathine penicillin G: A multinational cross‐sectional study (2020) (4)
- Progress towards a coordinated, national paediatric antimicrobial resistance surveillance programme: Staphylococcus aureus, enterococcal and Gram-negative bacteraemia in Australia. (2020) (4)
- 10-Valent pneumococcal non-typeable H. influenzae protein D conjugate vaccine (PHiD-CV10) versus 13-valent pneumococcal conjugate vaccine (PCV13) as a booster dose to broaden and strengthen protection from otitis media (PREVIX_BOOST) in Australian Aboriginal children: study protocol for a randomised (2020) (3)
- Improving primary prevention of acute rheumatic fever in Australia: consensus primary care priorities identified through an eDelphi process (2022) (3)
- Prevention of rheumatic fever. (2010) (3)
- Roadmap to incorporating group A Streptococcus molecular point‐of‐care testing for remote Australia: a key activity to eliminate rheumatic heart disease (2022) (3)
- Burden of Scabies and Skin Sores Among Children in Remote East Arnhem Aboriginal Communities of the Northern Territory (2006) (3)
- Host-dependent resistance of Group A Streptococcus to sulfamethoxazole mediated by a horizontally-acquired reduced folate transporter (2022) (3)
- An infant with fever and convulsions (1996) (3)
- Disseminated, multiclonal Epstein-Barr virus-associated lymphoproliferative disease in a patient with hematological and immunological anomalies. Molecular analysis correlates with morphological appearance. (1995) (3)
- Extreme preschool mobile preschool in Australia’s Northern Territory / (2011) (3)
- Additional file 1: Table S1. of Improving delivery of secondary prophylaxis for rheumatic heart disease in remote Indigenous communities: study protocol for a stepped-wedge randomised trial (2016) (3)
- Immunogenicity, otitis media, hearing impairment, and nasopharyngeal carriage 6-months after 13-valent or ten-valent booster pneumococcal conjugate vaccines, stratified by mixed priming schedules: PREVIX_COMBO and PREVIX_BOOST randomised controlled trials. (2022) (3)
- Comparison of group A streptococcal titres in healthy children and those with pharyngitis and skin infections. (2021) (3)
- High risk of early sub-therapeutic penicillin concentrations after intramuscular benzathine penicillin G injections in Ethiopian children and adults with rheumatic heart disease (2021) (2)
- Rheumatic Heart Disease in Pregnancy: New Strategies for an Old Disease? (2021) (2)
- Continued Challenge of Rheumatic Heart Disease (2013) (2)
- Key factors influencing educational outcomes for Indigenous students and their implications for planning and practice in the Northern Territory (2011) (2)
- PT443 Burden of Rheumatic Heart Disease in the Solomon Islands (2014) (2)
- Clinical Evaluation and Diagnosis of Acute Rheumatic Fever (2021) (2)
- The Spectrum, Severity and Outcomes of Rheumatic Mitral Valve Disease in Pregnant Women in Australia and New Zealand. (2021) (2)
- PO649 Tools For Implementing Rheumatic Heart Disease Control Programmes 2nd Edition Update (2018) (2)
- Perinatal risk factors associated with skin infection hospitalisation in Western Australian Aboriginal and Non-Aboriginal children. (2019) (2)
- Standardizing clinical care measures of rheumatic heart disease in pregnancy: A qualitative synthesis. (2019) (2)
- Group A Streptococcus (2012) (2)
- Community leadership and empowerment are essential for eliminating rheumatic heart disease. (2020) (2)
- Epidemiology of group A streptococcus in Australia (2009) (2)
- Epidemiology and global burden of rheumatic heart disease (2018) (2)
- PT299 The End RHD CRE. Developing an Endgame for Rheumatic Heart Disease in Australia (2016) (2)
- Time to address the neglected burden of group A Streptococcus (2021) (2)
- Ivermectin mass drug administration program to treat endemic scabies and strongyloidiasis in a remote aboriginal community in northern Australia (2011) (2)
- PO646 Benzathine Penicillin G Quality and Potency – Do We Need a New Manufacturing Standard? (2018) (1)
- Antibiotic prophylaxis for the prevention of recurrent urinary tract infections in children. (2006) (1)
- Contemporary Australian Profile of Rheumatic Fever: Results From Multiple Jurisdictions (2019) (1)
- Isolates pneumoniae Streptococcus Susceptibility Testing of Preparations for Antimicrobial Sheep Blood Mueller-Hinton Agar Citrated Sheep Blood , and Defibrinated Comparison of Citrated Human Blood (2010) (1)
- PM284 RHD Prevention and Control Programme in Tuvalu (2014) (1)
- Whole genome sequencing and molecular epidemiology of pediatric Staphylococcus aureus bacteremia. (2022) (1)
- The Benzathine Penicillin G (BPG) reformulation preferences study - towards a new Pencillin for Rheumatic Fever and Rheumatic Heart Disease (2017) (1)
- Penicillin Reactions in Patients With Severe Rheumatic Heart Disease: A Presidential Advisory From the American Heart Association (2022) (1)
- Invasive Infections Caused by Lancefield Groups C/G and A Streptococcus, Western Australia, Australia, 2000–2018 (2022) (1)
- The Cutter Incident: How America's First Polio Vaccine Led to the Growing Vaccine Crisis (2006) (1)
- Reply to letter regarding article, "Acute rheumatic fever and rheumatic heart disease: incidence and progression in the Northern Territory of Australia, 1997 to 2010". (2014) (1)
- OC02_10 Adherence to Secondary Prophylaxis for Rheumatic Heart Disease Patients Diagnosed Through Screening Is Inadequate for Disease Control (2016) (1)
- Defining and assessing the school readiness of Australian Indigenous children (2011) (1)
- Modelling study of the ability to diagnose acute rheumatic fever at different levels of the Ugandan healthcare system (2022) (1)
- Reply to “Susceptibility of Streptococcus pyogenes to Trimethoprim-Sulfamethoxazole” (2013) (1)
- O097 World Heart Federation evidence-based echocardiographic criteria for rheumatic heart disease allows for reproducible diagnosis (2014) (1)
- PT442 Disparity in Mortality Rates from Rheumatic Heart Disease in the Australian Indigenous and Non-Indigenous Populations (2014) (1)
- DURATION OF ANTIBIOTIC THERAPY IN CHILDREN WITH OSTEOMYELITIS AND SEPTIC ARTHRITIS (2005) (1)
- Atlas of group A streptococcal vaccine candidates compiled using large-scale comparative genomics (2019) (1)
- PO604 Rheumatic Heart Disease With Late Presentation Among Children In Malawi (2018) (1)
- PT441 The Global Burden of Rheumatic Heart Disease: The Tip of The Iceberg (2014) (1)
- Pain in the Backside: Exploring Subcutaneous Benzathine Penicillin G Acceptability (2019) (1)
- Correction to: Lessons learned in the development of sustained release penicillin drug delivery systems for the prophylactic treatment of rheumatic heart disease (RHD) (2018) (1)
- Antibiotic Prophylaxis and Recurrent Urinary Tract Infection in Children (vol 361, pg 1748, 2009) (2010) (1)
- Standardization of Epidemiological Surveillance of Group A Streptococcal Cellulitis (2022) (1)
- Group A Streptococcus (2019) (1)
- Bone and Joint Infections (2006) (1)
- O070 Echocardiographic screening for rheumatic heart disease in high-risk and low-risk children: results of the Australian gECHO study (2014) (1)
- Rheumatic Fever: What is New? (2015) (1)
- Harmonizing Surveillance Methodologies for Group A Streptococcal Diseases (2022) (1)
- The burden of bacterial skin infection, scabies and atopic dermatitis among urban-living Indigenous children in high-income countries: a protocol for a systematic review (2022) (1)
- Frequently asked questions about varicella vaccine (2005) (1)
- Rheumatic fever in Australian Indigenous children (2010) (1)
- PT288 The Concept and Design of Definerhd: A Study to Evaluate the Progression of Subclinical Rheumatic Valve Lesions Diagnosed Through Echocardiographic Screening (2016) (1)
- A Placebo-Controlled Randomized Trial of Antibiotics for the Prevention of Urinary Tract Infection in Children (2008) (1)
- , Melita Remote Tropical Communities Practical Alternative to Direct Plating in Recovering Streptococci from the Throat , a (2006) (1)
- Haemophilus influenzae type b infection in children in Pacific countries. (2004) (1)
- Modes of transmission and attack rates of group A Streptococcal infection: a protocol for a systematic review and meta-analysis (2021) (1)
- Acute rheumatic fever (ARF) in non-aboriginal patients in the Northern Territory. (1998) (1)
- Immunogenicity of a Third Scheduled Dose of Rotarix in Australian Indigenous Infants: A Phase IV, Double-blind, Randomized, Placebo-Controlled Clinical Trial (2022) (1)
- A Systematic Framework for Prioritizing Burden of Disease Data Required for Vaccine Development and Implementation: The Case for Group A Streptococcal Diseases (2022) (1)
- PW363 Echocardiographic Screening In A Resource Poor Setting: Borderline Rheumatic Heart Disease Could Be A Normal Variant (2014) (1)
- PO647 Adverse Events In Secondary Prophylaxis - Is Benzathine Penicillin G Really To Blame? (2018) (0)
- Preliminary consultation on preferred product characteristics of benzathine penicillin G for secondary prophylaxis of rheumatic fever (2016) (0)
- PW356 Epidemiology of rheumatic heart disease (RHD) in pregnancy: Australia and New Zealand (2014) (0)
- in Remote Aboriginal Communities aureus Staphylococcus Methicillin-Resistant Unique Epidemiology of Genotyping System To Demonstrate the Use of a Single-Nucleotide Polymorphism (2013) (0)
- , Flavia in Remote Aboriginal Communities aureus Staphylococcus Methicillin-Resistant Unique Epidemiology of Genotyping System To Demonstrate the Use of a Single-Nucleotide Polymorphism (2006) (0)
- PW355 Insights from the Pacific Rheumatic Heart Disease Prevention and Control Programme (2014) (0)
- Study protocol for controlled human infection for penicillin G against Streptococcus pyogenes: a double-blinded, placebo-controlled, randomised trial to determine the minimum concentration required to prevent experimental pharyngitis (the CHIPS trial) (2022) (0)
- PO617 A Better Understanding of Acute Rheumatic Fever In Uganda (2018) (0)
- 454. Perinatal Risk Factors Associated with Skin Infection Hospitalisation in Western Australian Aboriginal and Non-Aboriginal Children (2019) (0)
- Letter regarding article "Is primary prevention of rheumatic fever the missing link in the control of rheumatic fever in Africa? (2010) (0)
- Commentary on Remond et al. (2013) (0)
- The Benzathine Penicillin G (BPG) reformulation preferences study – the importance of cultural awareness and appropriate governance concerning Rheumatic Fever related research in New Zealand (2018) (0)
- Standardization of Epidemiological Surveillance of Rheumatic Heart Disease (2022) (0)
- PM466 RHD Prevention and Control Programme in the Republic of Kiribati (2014) (0)
- CONSENSUS DOCUMENT gRECS j The Second Rheumatic Heart Disease Forum Report (2013) (0)
- Preventing heart failure: a position paper of the Heart Failure Association in collaboration with the European Association of Preventive Cardiology. (2022) (0)
- Parent-Collected Specimens Using NL63, and Other Respiratory Viruses in Healthy Preschool-Aged Children Community Epidemiology of Human Metapneumovirus, Human Coronavirus (2010) (0)
- Ability of clinical to adhere to and isolates of group A streptococci invade HEp-2 epithelial cells (1998) (0)
- Unique Prospective Cohort Study: Rheumatic Heart Disease (RHD) and Pregnancy (2013) (0)
- The Benzathine Penicillin G (BPG) Reformulation Preferences Study - Tonga (2018) (0)
- 594 A Review of Cardiac Surgical Procedures and Outcomes for Paediatric Rheumatic Heart Disease in Western Australia From 2000-2018 (2020) (0)
- Reply to Banderet-Uglioni et al. (2015) (0)
- , S . Laboratories of Developing Countries to Citrated Human Blood Agar in Sheep Blood Agar Is a Practical Alternative As a Bacterial Culture Medium , Citrated (2006) (0)
- Body distribution of impetigo and association with host and pathogen factors (2022) (0)
- Fetal Alcohol Spectrum Disorder Survey for Youth Custodial Professionals (2020) (0)
- Better Care for Pregnant Women With RHD: What Works? (2019) (0)
- Human Rotavirus Vaccine during an Outbreak of Rotavirus G 2 P [ 4 ] Infection in Central Australia (2010) (0)
- RATIONALE FOR GROUP A STREPTOCOCCAL VACCINES (2013) (0)
- Accuracy of focussed cardiac ultrasound screening for rheumatic heart disease by health workers with limited training (2015) (0)
- Rheumatic heart disease mortality in Indigenous and non-Indigenous Australians between 2010 and 2017 (2023) (0)
- 20th International Symposium on Recent Advances in Otitis Media Podium Presentations (2019) (0)
- PT437 Working with health services: the AMOSS rheumatic heart disease (RHD) in pregnancy study (2014) (0)
- Endemic to the Setting or Not Are Titers Are Similar Whether Streptococci Normal Ranges of Streptococcal Antibody (2013) (0)
- Epidemiology of Rheumatic Heart Disease in Pregnancy in ANZ (2019) (0)
- A cost-effectiveness analysis of the management of sore throat in children in Australia (2006) (0)
- PS293 Improving Delivery of Secondary Prophylaxis for Rheumatic Heart Disease in Remote Indigenous Communities: A Stepped-Wedge, Community Randomised Trial (2016) (0)
- The burden of atopic dermatitis and bacterial skin infections among urban‐living Indigenous children and young people in high‐income countries: A systematic review (2022) (0)
- Qualitative assessment of healthy volunteer experience receiving subcutaneous infusions of high-dose benzathine penicillin G (SCIP) provides insights into design of late phase clinical studies (2023) (0)
- Aboriginal life pathways through multiple human service domains; administrative data linkage for policy (2018) (0)
- PM277 Accuracy of Focused Cardiac Ultrasound Screening for Rheumatic Heart Disease by Health Workers With Limited Training (2016) (0)
- Standardization of Epidemiological Surveillance of Acute Rheumatic Fever (2022) (0)
- Acute rheumatic fever and rheumatic heart disease in the Top End on Australia's Northern Territory. by Jonathan R. Carapetis, Don R. Wolff and Rart J. Currie (1995) (0)
- Charles Darwin University Pneumococcal conjugate vaccines PREVenar13 and SynflorIX in sequence or alone in high-risk Indigenous infants (PREV-IX_COMBO) protocol of a randomised controlled trial (2015) (0)
- Additional file 1: of Protocol for the systematic review of the prevention, treatment and public health management of impetigo, scabies and fungal skin infections in resource-limited settings (2016) (0)
- A Report on the Feasibility Study of the Proposed NT Pneumococcal Vaccine Trial (2002) (0)
- OC02_08 Validation of the World Heart Federation Evidence-Based Echocardiographic Criteria for Rheumatic Heart Disease (2016) (0)
- P3131Evolution of subclinical rheumatic heart disease: a multi-centre retrospective cohort study (2019) (0)
- The Benzathine Penicillin G (BPG) reformulation preferences study-edging closer towards a new Penicillin for Rheumatic Fever and Rheumatic Heart Disease (2018) (0)
- Culturally supported health promotion to See, Treat, Prevent (SToP) skin infections in Aboriginal children living in the Kimberley region of Western Australia: a qualitative analysis (2023) (0)
- Understanding protective plasma levels of penicillin and monitoring antibody responses for the prevention of GAS infection in a paediatric population in New Zealand (2018) (0)
- Standardization of Epidemiological Surveillance of Acute Poststreptococcal Glomerulonephritis (2022) (0)
- PS289 Challenges Facing Sustainability and Integration of RHD Control and Prevention Programmes in Pacific Small Island Nations (2016) (0)
- Potency – Do We Need a New Manufacturing Standard? (2019) (0)
- PT274 The Economic Case for a Group A Streptococcal Vaccine in Australia and New Zealand (2016) (0)
- PT296 Screening for Rheumatic Heart Disease and the Impact of Borderline RHD (2016) (0)
- Caring for Pregnant Women with Rheumatic Heart Disease: A Qualitative Study of Health Service Provider Perspectives (2021) (0)
- APSC2015-1148 Are Minor Echocardiographic Changes Associated With an Increased Risk of Acute Rheumatic Fever or Progression to Rheumatic Heart Disease? (2015) (0)
- Articulating the Endgame for Rheumatic Heart Disease in Australia (2019) (0)
- Correction to: Lessons learned in the development of sustained release penicillin drug delivery systems for the prophylactic treatment of rheumatic heart disease (RHD) (2018) (0)
- 669Rheumatic Heart Disease outcomes in Australia: a linked data analysis (2021) (0)
- Development of vaccines to prevent Group A streptococcal infections and rheumatic fever (2010) (0)
- Cover story: Plain speaking (2012) (0)
- Reference exome data for Australian Aboriginal populations to support health-based research (2020) (0)
- Acute Rheumatic Fever Case Definition (0)
- PT298 A Cost Utility Analysis of Echocardiographic Screening for Rheumatic Heart Disease in Indigenous Australian Children (2016) (0)
- PT277 Group A Streptococcus Induces a TH17 Response in Acute Rheumatic Fever Effectively Targeted by Drug Repurposing (2016) (0)
- An infant with fever and convulsions. Bacteroides fragilis brain abscess and meningitis. (1996) (0)
- Standardization of Epidemiological Surveillance of Invasive Group A Streptococcal Infections (2022) (0)
- Towards understanding the pathogenesis of rheumatic fever. Commentary (1996) (0)
- Penicillin G concentrations required for prophylaxis against Group A Streptococcus infection evaluated using a hollow fibre model and mathematical modelling (2022) (0)
- Starting the SToP trial: Lessons from a collaborative recruitment approach (2022) (0)
- Kinetics of once daily gentamicin in children: are we using the right dose? (2000) (0)
- Population pharmacokinetic study of benzathine penicillin G administration in Indigenous children and young adults with rheumatic heart disease in the Northern Territory, Australia. (2022) (0)
- A pilot study to develop assessment tools for Group A Streptococcus surveillance studies (2023) (0)
- PT430 Involvement of Th17 cytokines in acute rheumatic fever (2014) (0)
- AN D THE COMMU NITY B-cell antigen D 8 / 17 is a marker of rheumatic fever susceptibility in Aboriginal Australians and can be tested in remote settings (2006) (0)
- Standardization of Epidemiological Surveillance of Group A Streptococcal Pharyngitis (2022) (0)
- APSC2015-1151 Can Minor Echocardiographic Changes Predict Future Progression to Rheumatic Heart Disease? (2015) (0)
- Establishing Cutoffs for Streptococcal Antibody Titers in Uganda: Implications for Rheumatic Fever Diagnosis (2019) (0)
- PT291 Global Status Update on Benzathine Penicillin G (2016) (0)
- PT287 Rheumatic Heart Disease Severity, Progression and Outcomes: A Multi-State Model (2016) (0)
- Standardization of Epidemiological Surveillance of Group A Streptococcal Impetigo (2022) (0)
- Reference exome data for Australian Aboriginal populations to support health-based research (2020) (0)
- PO648 Benzathine Penicillin G Pharmacokinetics In a Predominately Australian Aboriginal Adolescent Population, a Prospective Observational Study (2018) (0)
- Antibiotic Consumption for Sore Throat and the Potential Effect of a Vaccine Against Group A Streptococcus: A Systematic Review and Modelling Study (2023) (0)
- Missing Link in the Control of Rheumatic Heart Disease in Africa?'' Letter by Carapetis Regarding Article, ''Is Primary Prevention of Rheumatic Fever the (2014) (0)
- List of Contributors (2020) (0)
- List of Contributors (2021) (0)
- serves as a new tool for molecular typing and vaccine development (2014) (0)
- Lessons learned in the development of sustained release penicillin drug delivery systems for the prophylactic treatment of rheumatic heart disease (RHD) (2018) (0)
- Controlling rheumatic heart disease in developing countries : : editorial (2006) (0)
- tatus of research and development of vaccines for treptococcus pyogenes ndrew (2016) (0)
- Protocol_PneuMum_Final v3 9Feb2010 (2010) (0)
This paper list is powered by the following services:
Other Resources About Jonathan Carapetis
What Schools Are Affiliated With Jonathan Carapetis?
Jonathan Carapetis is affiliated with the following schools:
